https://www.selleckchem.com/products/azd1080.html
9%). Pacemaker insertion was required in 76.3% of the patients, most of which were permanent implants (45.8%). This systematic review summarizes the current evidence and characteristics of bradyarrhythmia in patients with COVID-19. Further studies are critical to assess the reversibility of bradyarrhythmia in COVID-19 patients and to clarify potential therapeutic targets including the need for permanent pacing. Checklists are memory recall tools used across healthcare to improve outcomes. Here, we describe the development and evaluation
Aimer
Commentaire
Partagez
